Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Steven Kozlowski is active.

Publication


Featured researches published by Steven Kozlowski.


Molecular Immunology | 1994

Minimal requirements for peptide mediated activation of CD8+ CTL.

Richard C. Brower; Richard England; Toshiyuki Takeshita; Steven Kozlowski; David H. Margulies; Jay A. Berzofsky; Charles DeLisi

A physical chemical model of T cell stimulation by class I-peptide complexes was developed and used to analyse in vitro studies of gamma-interferon release as a function of the number of peptide and MHC molecules. The analysis provided reasonable estimates of well identified parameters, including equilibrium constants and the minimum number of T cell receptor-class I-peptide ternary complexes on a presenting cell required to activate T cells. The latter number was estimated as 3-5 per T cell. This is in distinct contrast to estimates in the literature of the number of peptide-MHC complexes required for activity, which is necessarily larger. The analysis also predicted that activity is potentiated by interaction between class I molecules, even if one member of the pair is not bound by antigen. The analytical approach used in this paper may be applicable to other activation systems.


Multivalent requirement for the stimulation of alloreactive T cells: studies with engineered soluble MHC class I proteins in vitro and in vivo. | 1990

Multivalent Requirement for the Stimulation of Alloreactive T Cells: Studies with Engineered Soluble MHC Class I Proteins In Vitro and In Vivo

David H. Margulies; Lisa F. Boyd; Steven Kozlowski; L. Kjer-Nielsen; R. Lopez; J. McCluskey; J. Schneck; R. Hunziker

The murine class I major histocompatibility antigens play critical roles in the interaction of class I-restricted T cell receptors with their stimulatory or target antigen presenting cells. One approach taken by our laboratories has been to investigate the biological activity of genetically engineered, soluble, homogenous, purified class I molecules in the stimulation and inhibition of allospecific T cell hybridomas (Margulies et al, 1986; McCluskey et al, 1988; Schneck et al, 1989a). More recently we have established a system for comparing the role of the cell surface multivalent display of the MHC molecule with these monovalent soluble analogues expressed in vivo in transgenic mice. In this brief review, we hope to recount the logic by which the initial soluble class I MHC molecules were generated, summarize previously published as well as unpublished data on their expression and function, and present some preliminary evidence suggesting that transgenic mice expressing soluble analogues of the H-2Dd protein in a C57B1/6 background will be useful for studies of the molecular and biochemical basis of the generation of immunological tolerance to class I molecules.


Archive | 1993

Class I MHC/Peptide/ β 2-Microglobulin Interactions:The Basis of Cytotoxic T-Cell Recognition

David H. Margulies; Lisa F. Boyd; Maripat Corr; Rosemarie Hunziker; Sergei Khilko; Steven Kozlowski; Michael G. Mage; Randall K. Ribaudo

The past decade has witnessed a major revolution in our thinking and understanding of the molecular basis of T-cell recognition. In this brief review we outline the historical development of this knowledge and how it has drawn upon advances in cellular immunology, virology, genetics, molecular biology, and structural biology. The current status of our view of the molecular details is summarized, and an outline of critical molecular and cellular questions for the future is presented.


Journal of Experimental Medicine | 1992

Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.

Maripat Corr; Lisa F. Boyd; S R Frankel; Steven Kozlowski; Eduardo A. Padlan; David H. Margulies


Nature | 1991

Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules.

Steven Kozlowski; Toshiyuki Takeshita; Wolf-Henning Boehncke; Hidemi Takahashi; Lisa F. Boyd; Ronald N. Germain; Jay A. Berzofsky; David H. Margulies


Journal of Experimental Medicine | 1992

Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules.

Steven Kozlowski; Maripat Corr; Toshiyuki Takeshita; Lisa F. Boyd; C D Pendleton; Ronald N. Germain; Jay A. Berzofsky; David H. Margulies


Proceedings of the National Academy of Sciences of the United States of America | 1992

A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity.

Michael G. Mage; L Lee; Randall K. Ribaudo; Maripat Corr; Steven Kozlowski; Louise McHugh; David H. Margulies


Proceedings of the National Academy of Sciences of the United States of America | 1992

Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of beta 2-microglobulin.

Lisa F. Boyd; Steven Kozlowski; David H. Margulies


European Journal of Immunology | 1994

Functional cell surface expression by a recombinant single-chain class I major histocompatibility complex molecule with a cis-active β2-microglobulin domain

Li Lee; Louise McHugh; Randall K. Ribaudo; Steven Kozlowski; David H. Margulies; Michael G. Mage


International Immunology | 1993

Role of conserved regions of class I MHC molecules in the activation of CD8+ cytotoxic T lymphocytes by peptide and purified cell-free class I molecules

Toshiyuki Takeshita; Steven Kozlowski; Richard England; Richard Brower; Jonathan P. Schneck; Hidemi Takahashi; Charles DeLisl; David H. Margulies; Jay A. Berzofsky

Collaboration


Dive into the Steven Kozlowski's collaboration.

Top Co-Authors

Avatar

David H. Margulies

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jay A. Berzofsky

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Lisa F. Boyd

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Maripat Corr

University of California

View shared research outputs
Top Co-Authors

Avatar

Toshiyuki Takeshita

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Michael G. Mage

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Randall K. Ribaudo

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

C. David Pendleton

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Louise McHugh

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Richard England

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge